Red blood cell glucose metabolism in Down's syndrome.
The specific activity of red blood cell glycolytic enzymes was determined in 20 Down's syndrome patients and compared with 20 normal controls. According to previous evidence, a 50% increase of phosphofructokinase and a 30% increase of glucose-6-phosphate dehydrogenase and glutathione peroxidase activity was found. Metabolic studies of the patients' erythrocytes revealed a decrease in fructose-6-phosphate and 2, 3-diphosphoglycerate concentrations, while fructose-1, 6-diphosphate and ADP both increased. Glucose utilization by intact erythrocytes from Down's syndrome patients did not differ from that of normal controls. However, addition of methylene blue or inorganic phosphate produced a higher stimulation of erythrocyte glycolysis in patients with Down's syndrome compared to controls. These metabolic abnormalities could be, at least in part, ascribed to the increased phosphofructokinase activity which is due to a gene-dosage effect.
D001786:Blood Glucose / Q000378:metabolism*; D004314:Down Syndrome / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006019:Glycolysis; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D010732:Phosphofructokinase-1 / Q000097:blood*
D001786:Blood Glucose; D007527:Isoenzymes; D010732:Phosphofructokinase-1